Clinical Trial Update: Comparing the Rate of Insufficient Cells for Diagnosis Between Surepath® and Conventional Smear in Women After Radiation Therapy for Cervical Cancer [NA]

View source ↗

Summary

A completed clinical trial comparing SurePath® versus conventional smear for diagnostic cell sufficiency after radiation therapy in cervical cancer patients; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• SurePath®

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Cervical Cancer | NA | Status: COMPLETED | Results posted: 2018-11-20